These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2548232)

  • 1. Acute skin reactions observed in fractionated proton irradiation.
    Arimoto T; Maruhashi N; Takada Y; Hayakawa Y; Inada T; Kitagawa T
    Radiat Med; 1989; 7(1):23-7. PubMed ID: 2548232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton therapy in Japan.
    Tsunemoto H; Morita S; Ishikawa T; Furukawa S; Kawachi K; Kanai T; Ohara H; Kitagawa T; Inada T
    Radiat Res Suppl; 1985; 8():S235-43. PubMed ID: 3003785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative biological effectiveness of the modulated proton beam at TRIUMF.
    Nemoto K; Pickles T; Minchinton AI; Lam GK
    Radiat Med; 1998; 16(1):43-6. PubMed ID: 9568632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RBE of neutrons from the BR-10 reactor based on their antitumor effect and on acute radiation reactions of the skin].
    Kuznetsova MN; Ul'ianenko SE
    Med Radiol (Mosk); 1989 May; 34(5):45-8. PubMed ID: 2725191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray therapy.
    Bush DA; Slater JD; Garberoglio C; Yuh G; Hocko JM; Slater JM
    Cancer J; 2007; 13(2):114-8. PubMed ID: 17476139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of ultra high energy neutron beam generated by 500 MeV proton beam].
    Inada T; Hayakawa Y; Arimoto T; Kubota N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Apr; 50(4):404-11. PubMed ID: 2167461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proton beam therapy].
    Kitagawa T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):878-84. PubMed ID: 3008670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute skin reactions of a miniature pig MINI-LEWE following single or fractionated local irradiation with 250 kv x-rays or 6.2 mev neutron rays (author's transl)].
    Magdon E; Winterfeld G; Kujawa G; Klaus H; Schröder E
    Radiobiol Radiother (Berl); 1981; 22(5):615-23. PubMed ID: 6803291
    [No Abstract]   [Full Text] [Related]  

  • 11. Biophysical modelling of proton radiation effects based on amorphous track models.
    Paganetti H; Goitein M
    Int J Radiat Biol; 2001 Sep; 77(9):911-28. PubMed ID: 11576451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute skin reactions in rats after irradiation with reactor neutrons].
    Kuznetsova MN; Ul'ianenko SE; Sysoev AS
    Med Radiol (Mosk); 1990 Jul; 35(7):43-5. PubMed ID: 2374485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RBE of 2.2-BeV protons for 30-day lethality in mice.
    Jesseph JE; Moore WH; Straub RF; Tisljar-Lentulis GM; Bond VP
    Radiat Res; 1968 Nov; 36(2):242-53. PubMed ID: 17387943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproton radiotherapy.
    Bassler N; Alsner J; Beyer G; DeMarco JJ; Doser M; Hajdukovic D; Hartley O; Iwamoto KS; Jäkel O; Knudsen HV; Kovacevic S; Møller SP; Overgaard J; Petersen JB; Solberg TD; Sørensen BS; Vranjes S; Wouters BG; Holzscheiter MH
    Radiother Oncol; 2008 Jan; 86(1):14-9. PubMed ID: 18158194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay.
    Wouters BG; Lam GK; Oelfke U; Gardey K; Durand RE; Skarsgard LD
    Radiat Res; 1996 Aug; 146(2):159-70. PubMed ID: 8693066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo radiobiological characterization of proton beam at the National Cancer Center in Korea: effect of the Chk2 mutation.
    Kim SS; Choo DW; Shin D; Baek HJ; Kim TH; Motoyama N; De Coster BM; Gueulette J; Furusawa Y; Ando K; Cho KH
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):559-62. PubMed ID: 21195877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.